Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
Authors:
- Nathalie A. LengacherNLNathalie A. Lengacher
- Julianna J. TomlinsonJTJulianna J. Tomlinson
- Ann-Kristin JochumAJAnn-Kristin Jochum
- Jonas FranzJFJonas Franz
- Omar Hasan AliOAOmar Hasan Ali
- Lukas FlatzLFLukas Flatz
- Josef PenningerJPJosef Penninger
- Christine Stadelmann-NesslerCSChristine Stadelmann-Nessler
- John M. WoulfeJWJohn M. Woulfe
- Michael G. SchlossmacherMSMichael G. Schlossmacher
Preprint
Abstract
Summary: The majority of patients with Parkinson disease (PD) experience a loss in their sense of smell and accumulate insoluble α-synuclein aggregates in their olfactory bulbs (OB). Subjects affected by a SARS-CoV-2-linked illness (COVID-19) frequently experience hyposmia. We previously hypothesized that α-synuclein and tau misprocessing could occur following host responses to microbial triggers. Using semiquantitative measurements of immunohistochemical signals, we examined OB and olfactory tract specimens collected serially at autopsies between 2020 and 2023. Deceased subjects comprised 50 adults, which included COVID19+ patients (n=22), individuals with Lewy body disease (e.g., PD and dementia with Lewy bodies (DLB; n=6)), Alzheimer disease (AD; n=3), other non-synucleinopathy-linked degenerative diseases (e.g., progressive supranuclear palsy (PSP; n=2) and multisystem atrophy (MSA; n=1)). Further, we included neurologically healthy controls (HCO; n=9) and those with an inflammation-rich brain disorder as neurological controls (NCO; n=7). When probing for inflammatory changes focusing on anterior olfactory nuclei (AON) using anti-CD68 immunostaining, scores were consistently elevated in NCO and AD cases. In contrast, inflammation on average was not significantly altered in COVID19+ patients relative to controls, although anti-CD68 reactivity in their OB and tracts declined with progression in age. Mild-to-moderate increases in phospho-αSyn and phospho-tau signals were detected in the AON of tauopathy-and synucleinopathy-afflicted brains, respectively, consistent with mixed pathology, as described by others. Lastly, when both sides were available for comparison in our case series, we saw no asymmetry in the degree of pathology of the left versus right OB and tracts. We concluded from our autopsy series that after a fatal course of COVID-19, microscopic changes -when present-in the rostral, intracranial portion of the olfactory circuitry generally reflected neurodegenerative processes seen elsewhere in the brain. In general, inflammation correlated best with the degree of Alzheimer’s-linked tauopathy and declined with progression of age in COVID19+ patients.Keywords
All Related Versions
- Published version: Acta Neuropathologica Communications, 12 (1), 1.
This publication has 46 references indexed in Scilit:
- Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent mannerScience Translational Medicine, 2019
- Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain InfectionNeuron, 2018
- Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effectsJournal of Neural Transmission, 2017
- Alpha-Synuclein Expression Restricts RNA Viral Infections in the BrainJournal of Virology, 2016
- Parkinson's diseaseThe Lancet, 2015
- Friend or Foe? IgLON5 antibodies in a novel tauopathy with prominent sleep movement disorder, ataxia, and choreaMovement Disorders, 2014
- OMERO: flexible, model-driven data management for experimental biologyNature Methods, 2012
- Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's diseaseNature Medicine, 2008
- Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ɛ4Neuropathology and Applied Neurobiology, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003